Author:
Afifah Astari Rahayu,Liana Phey,Fertilita Soilia,Salim Nelda Aprilia,Verdiansah Verdiansah,Hilda Fadhilatul,Amin Chris Alberto,Umar Tungki Pratama
Abstract
Coronavirus Disease 2019 (COVID-19) confirmed cases and deaths continue to rise. When a virus infects the body, the immune system tries to eliminate the virus. C-Reactive Protein (CRP) is a substance produced in the body in response to infection and inflammation. The study aimed to determine the role of CRP in predicting COVID-19 patients’ mortality. From the 1st of March to the 31st of August 2020, data on patients confirmed with COVID-19 were collected from medical records. The correlation between CRP levels and patient mortality was determined using a Chi-Square test. A Receiver Operator Curve (ROC) analysis was used to determine the best CRP cut-off point, and a survival analysis was used to assess the patient outcome. This study included a total of 210 eligible patients. Survivors and non-survivors were divided into two groups of patients (159 patients and 51 patients, respectively). The CRP cut-off was 54 mg/L, with an AUC of 0.817 (p<0.001). C-reactive protein levels were related to COVID-19 patient mortality (p=0.000). According to the survival analysis, patients with CRP levels > 54 mg/L had a lower chance of 30-day survival (p=0.0001). This study presented that CRP levels can be used to predict mortality in COVID-19 patients.
Reference32 articles.
1. Farahat RA, Abdelaal A, Umar TP, El-Sakka AA, Benmelouka AY, et al. The emergence of SARS-CoV-2 Omicron subvariants: Current situation and future trends. Le Infez Med, 2022; 30(4): 480.
2. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response;Astuti;Diabetes Metab Syndr Clin Res Rev,2020
3. World Health Organization. WHO Coronavirus Disease Dashboard [Internet]. World Health Organization. 2022 Available from: https://covid19.who.int/(accessed Jan 7, 2022).
4. COVID-19 Response Acceleration Task Force. COVID-19 Distribution data of Indonesia [Internet]. The Ministry of Health of Indonesia. 2022. Available from: https://covid19.go.id/peta-sebaran (accessed Jan 9, 2022).
5. Diagnostic utility of clinical laboratory data determinations for patients with severe COVID-19;Gao;J Med Virol,2020